 | • レポートコード：MRC2-11QY12870 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は未分画ヘパリンのグローバル市場について調査・分析したレポートです。種類別（牛、豚）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別未分画ヘパリンの競争状況、市場シェア ・世界の未分画ヘパリン市場：種類別市場規模 2015年-2020年（牛、豚） ・世界の未分画ヘパリン市場：種類別市場規模予測 2021年-2026年（牛、豚） ・世界の未分画ヘパリン市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の未分画ヘパリン市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の未分画ヘパリン市場分析：米国、カナダ ・ヨーロッパの未分画ヘパリン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの未分画ヘパリン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の未分画ヘパリン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの未分画ヘパリン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter International Inc.、B. Braun Melsungen AG、Fresenius SE & Co. KGaA、LEO Pharma A/S、Sagent Pharmaceuticals、Pfizer, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Unfractionated Heparin Market
The global Unfractionated Heparin market size is projected to reach US$ 978.8 million by 2026, from US$ 941.8 million in 2020, at a CAGR of 3.6%% during 2021-2026.
Global Unfractionated Heparin Scope and Market Size
Unfractionated Heparin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Unfractionated Heparin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Unfractionated Heparin market is segmented into
Bovine
Porcine
Segment by Application, the Unfractionated Heparin market is segmented into
Hospitals
Clinics
Other
Regional and Country-level Analysis
The Unfractionated Heparin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Unfractionated Heparin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Unfractionated Heparin Market Share Analysis
Unfractionated Heparin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Unfractionated Heparin business, the date to enter into the Unfractionated Heparin market, Unfractionated Heparin product introduction, recent developments, etc.
The major vendors covered:
Baxter International Inc.
B. Braun Melsungen AG
Fresenius SE & Co. KGaA
LEO Pharma A/S
Sagent Pharmaceuticals
Pfizer, Inc.
…
1 Study Coverage
1.1 Unfractionated Heparin Product Introduction
1.2 Market Segments
1.3 Key Unfractionated Heparin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Unfractionated Heparin Market Size Growth Rate by Type
1.4.2 Bovine
1.4.3 Porcine
1.5 Market by Application
1.5.1 Global Unfractionated Heparin Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Unfractionated Heparin Market Size, Estimates and Forecasts
2.1.1 Global Unfractionated Heparin Revenue 2015-2026
2.1.2 Global Unfractionated Heparin Sales 2015-2026
2.2 Global Unfractionated Heparin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Unfractionated Heparin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Unfractionated Heparin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Unfractionated Heparin Competitor Landscape by Players
3.1 Unfractionated Heparin Sales by Manufacturers
3.1.1 Unfractionated Heparin Sales by Manufacturers (2015-2020)
3.1.2 Unfractionated Heparin Sales Market Share by Manufacturers (2015-2020)
3.2 Unfractionated Heparin Revenue by Manufacturers
3.2.1 Unfractionated Heparin Revenue by Manufacturers (2015-2020)
3.2.2 Unfractionated Heparin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Unfractionated Heparin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Unfractionated Heparin Revenue in 2019
3.2.5 Global Unfractionated Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Unfractionated Heparin Price by Manufacturers
3.4 Unfractionated Heparin Manufacturing Base Distribution, Product Types
3.4.1 Unfractionated Heparin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Unfractionated Heparin Product Type
3.4.3 Date of International Manufacturers Enter into Unfractionated Heparin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Unfractionated Heparin Market Size by Type (2015-2020)
4.1.1 Global Unfractionated Heparin Sales by Type (2015-2020)
4.1.2 Global Unfractionated Heparin Revenue by Type (2015-2020)
4.1.3 Unfractionated Heparin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Unfractionated Heparin Market Size Forecast by Type (2021-2026)
4.2.1 Global Unfractionated Heparin Sales Forecast by Type (2021-2026)
4.2.2 Global Unfractionated Heparin Revenue Forecast by Type (2021-2026)
4.2.3 Unfractionated Heparin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Unfractionated Heparin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Unfractionated Heparin Market Size by Application (2015-2020)
5.1.1 Global Unfractionated Heparin Sales by Application (2015-2020)
5.1.2 Global Unfractionated Heparin Revenue by Application (2015-2020)
5.1.3 Unfractionated Heparin Price by Application (2015-2020)
5.2 Unfractionated Heparin Market Size Forecast by Application (2021-2026)
5.2.1 Global Unfractionated Heparin Sales Forecast by Application (2021-2026)
5.2.2 Global Unfractionated Heparin Revenue Forecast by Application (2021-2026)
5.2.3 Global Unfractionated Heparin Price Forecast by Application (2021-2026)
6 North America
6.1 North America Unfractionated Heparin by Country
6.1.1 North America Unfractionated Heparin Sales by Country
6.1.2 North America Unfractionated Heparin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Unfractionated Heparin Market Facts & Figures by Type
6.3 North America Unfractionated Heparin Market Facts & Figures by Application
7 Europe
7.1 Europe Unfractionated Heparin by Country
7.1.1 Europe Unfractionated Heparin Sales by Country
7.1.2 Europe Unfractionated Heparin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Unfractionated Heparin Market Facts & Figures by Type
7.3 Europe Unfractionated Heparin Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Unfractionated Heparin by Region
8.1.1 Asia Pacific Unfractionated Heparin Sales by Region
8.1.2 Asia Pacific Unfractionated Heparin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Unfractionated Heparin Market Facts & Figures by Type
8.3 Asia Pacific Unfractionated Heparin Market Facts & Figures by Application
9 Latin America
9.1 Latin America Unfractionated Heparin by Country
9.1.1 Latin America Unfractionated Heparin Sales by Country
9.1.2 Latin America Unfractionated Heparin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Unfractionated Heparin Market Facts & Figures by Type
9.3 Central & South America Unfractionated Heparin Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Unfractionated Heparin by Country
10.1.1 Middle East and Africa Unfractionated Heparin Sales by Country
10.1.2 Middle East and Africa Unfractionated Heparin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Unfractionated Heparin Market Facts & Figures by Type
10.3 Middle East and Africa Unfractionated Heparin Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Unfractionated Heparin Products Offered
11.1.5 Baxter International Inc. Related Developments
11.2 B. Braun Melsungen AG
11.2.1 B. Braun Melsungen AG Corporation Information
11.2.2 B. Braun Melsungen AG Description and Business Overview
11.2.3 B. Braun Melsungen AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 B. Braun Melsungen AG Unfractionated Heparin Products Offered
11.2.5 B. Braun Melsungen AG Related Developments
11.3 Fresenius SE & Co. KGaA
11.3.1 Fresenius SE & Co. KGaA Corporation Information
11.3.2 Fresenius SE & Co. KGaA Description and Business Overview
11.3.3 Fresenius SE & Co. KGaA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Fresenius SE & Co. KGaA Unfractionated Heparin Products Offered
11.3.5 Fresenius SE & Co. KGaA Related Developments
11.4 LEO Pharma A/S
11.4.1 LEO Pharma A/S Corporation Information
11.4.2 LEO Pharma A/S Description and Business Overview
11.4.3 LEO Pharma A/S Sales, Revenue and Gross Margin (2015-2020)
11.4.4 LEO Pharma A/S Unfractionated Heparin Products Offered
11.4.5 LEO Pharma A/S Related Developments
11.5 Sagent Pharmaceuticals
11.5.1 Sagent Pharmaceuticals Corporation Information
11.5.2 Sagent Pharmaceuticals Description and Business Overview
11.5.3 Sagent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sagent Pharmaceuticals Unfractionated Heparin Products Offered
11.5.5 Sagent Pharmaceuticals Related Developments
11.6 Pfizer, Inc.
11.6.1 Pfizer, Inc. Corporation Information
11.6.2 Pfizer, Inc. Description and Business Overview
11.6.3 Pfizer, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer, Inc. Unfractionated Heparin Products Offered
11.6.5 Pfizer, Inc. Related Developments
11.1 Baxter International Inc.
11.1.1 Baxter International Inc. Corporation Information
11.1.2 Baxter International Inc. Description and Business Overview
11.1.3 Baxter International Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter International Inc. Unfractionated Heparin Products Offered
11.1.5 Baxter International Inc. Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Unfractionated Heparin Market Estimates and Projections by Region
12.1.1 Global Unfractionated Heparin Sales Forecast by Regions 2021-2026
12.1.2 Global Unfractionated Heparin Revenue Forecast by Regions 2021-2026
12.2 North America Unfractionated Heparin Market Size Forecast (2021-2026)
12.2.1 North America: Unfractionated Heparin Sales Forecast (2021-2026)
12.2.2 North America: Unfractionated Heparin Revenue Forecast (2021-2026)
12.2.3 North America: Unfractionated Heparin Market Size Forecast by Country (2021-2026)
12.3 Europe Unfractionated Heparin Market Size Forecast (2021-2026)
12.3.1 Europe: Unfractionated Heparin Sales Forecast (2021-2026)
12.3.2 Europe: Unfractionated Heparin Revenue Forecast (2021-2026)
12.3.3 Europe: Unfractionated Heparin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Unfractionated Heparin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Unfractionated Heparin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Unfractionated Heparin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Unfractionated Heparin Market Size Forecast by Region (2021-2026)
12.5 Latin America Unfractionated Heparin Market Size Forecast (2021-2026)
12.5.1 Latin America: Unfractionated Heparin Sales Forecast (2021-2026)
12.5.2 Latin America: Unfractionated Heparin Revenue Forecast (2021-2026)
12.5.3 Latin America: Unfractionated Heparin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Unfractionated Heparin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Unfractionated Heparin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Unfractionated Heparin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Unfractionated Heparin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Unfractionated Heparin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Unfractionated Heparin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Unfractionated Heparin Market Segments
Table 2. Ranking of Global Top Unfractionated Heparin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Unfractionated Heparin Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Bovine
Table 5. Major Manufacturers of Porcine
Table 6. Global Unfractionated Heparin Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Unfractionated Heparin Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Unfractionated Heparin Sales by Regions 2015-2020 (K MT)
Table 9. Global Unfractionated Heparin Sales Market Share by Regions (2015-2020)
Table 10. Global Unfractionated Heparin Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Unfractionated Heparin Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Unfractionated Heparin Sales Share by Manufacturers (2015-2020)
Table 13. Global Unfractionated Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Unfractionated Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Unfractionated Heparin as of 2019)
Table 15. Unfractionated Heparin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Unfractionated Heparin Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Unfractionated Heparin Price (2015-2020) (USD/MT)
Table 18. Unfractionated Heparin Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Unfractionated Heparin Product Type
Table 20. Date of International Manufacturers Enter into Unfractionated Heparin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Unfractionated Heparin Sales by Type (2015-2020) (K MT)
Table 23. Global Unfractionated Heparin Sales Share by Type (2015-2020)
Table 24. Global Unfractionated Heparin Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Unfractionated Heparin Revenue Share by Type (2015-2020)
Table 26. Unfractionated Heparin Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Unfractionated Heparin Sales by Application (2015-2020) (K MT)
Table 28. Global Unfractionated Heparin Sales Share by Application (2015-2020)
Table 29. North America Unfractionated Heparin Sales by Country (2015-2020) (K MT)
Table 30. North America Unfractionated Heparin Sales Market Share by Country (2015-2020)
Table 31. North America Unfractionated Heparin Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Unfractionated Heparin Revenue Market Share by Country (2015-2020)
Table 33. North America Unfractionated Heparin Sales by Type (2015-2020) (K MT)
Table 34. North America Unfractionated Heparin Sales Market Share by Type (2015-2020)
Table 35. North America Unfractionated Heparin Sales by Application (2015-2020) (K MT)
Table 36. North America Unfractionated Heparin Sales Market Share by Application (2015-2020)
Table 37. Europe Unfractionated Heparin Sales by Country (2015-2020) (K MT)
Table 38. Europe Unfractionated Heparin Sales Market Share by Country (2015-2020)
Table 39. Europe Unfractionated Heparin Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Unfractionated Heparin Revenue Market Share by Country (2015-2020)
Table 41. Europe Unfractionated Heparin Sales by Type (2015-2020) (K MT)
Table 42. Europe Unfractionated Heparin Sales Market Share by Type (2015-2020)
Table 43. Europe Unfractionated Heparin Sales by Application (2015-2020) (K MT)
Table 44. Europe Unfractionated Heparin Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Unfractionated Heparin Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Unfractionated Heparin Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Unfractionated Heparin Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Unfractionated Heparin Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Unfractionated Heparin Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Unfractionated Heparin Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Unfractionated Heparin Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Unfractionated Heparin Sales Market Share by Application (2015-2020)
Table 53. Latin America Unfractionated Heparin Sales by Country (2015-2020) (K MT)
Table 54. Latin America Unfractionated Heparin Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Unfractionated Heparin Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Unfractionated Heparin Revenue Market Share by Country (2015-2020)
Table 57. Latin America Unfractionated Heparin Sales by Type (2015-2020) (K MT)
Table 58. Latin America Unfractionated Heparin Sales Market Share by Type (2015-2020)
Table 59. Latin America Unfractionated Heparin Sales by Application (2015-2020) (K MT)
Table 60. Latin America Unfractionated Heparin Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Unfractionated Heparin Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Unfractionated Heparin Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Unfractionated Heparin Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Unfractionated Heparin Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Unfractionated Heparin Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Unfractionated Heparin Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Unfractionated Heparin Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Unfractionated Heparin Sales Market Share by Application (2015-2020)
Table 69. Baxter International Inc. Corporation Information
Table 70. Baxter International Inc. Description and Major Businesses
Table 71. Baxter International Inc. Unfractionated Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Baxter International Inc. Product
Table 73. Baxter International Inc. Recent Development
Table 74. B. Braun Melsungen AG Corporation Information
Table 75. B. Braun Melsungen AG Description and Major Businesses
Table 76. B. Braun Melsungen AG Unfractionated Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. B. Braun Melsungen AG Product
Table 78. B. Braun Melsungen AG Recent Development
Table 79. Fresenius SE & Co. KGaA Corporation Information
Table 80. Fresenius SE & Co. KGaA Description and Major Businesses
Table 81. Fresenius SE & Co. KGaA Unfractionated Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Fresenius SE & Co. KGaA Product
Table 83. Fresenius SE & Co. KGaA Recent Development
Table 84. LEO Pharma A/S Corporation Information
Table 85. LEO Pharma A/S Description and Major Businesses
Table 86. LEO Pharma A/S Unfractionated Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. LEO Pharma A/S Product
Table 88. LEO Pharma A/S Recent Development
Table 89. Sagent Pharmaceuticals Corporation Information
Table 90. Sagent Pharmaceuticals Description and Major Businesses
Table 91. Sagent Pharmaceuticals Unfractionated Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Sagent Pharmaceuticals Product
Table 93. Sagent Pharmaceuticals Recent Development
Table 94. Pfizer, Inc. Corporation Information
Table 95. Pfizer, Inc. Description and Major Businesses
Table 96. Pfizer, Inc. Unfractionated Heparin Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. Pfizer, Inc. Product
Table 98. Pfizer, Inc. Recent Development
Table 99. Global Unfractionated Heparin Sales Forecast by Regions (2021-2026) (K MT)
Table 100. Global Unfractionated Heparin Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Unfractionated Heparin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Unfractionated Heparin Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Unfractionated Heparin Sales Forecast by Country (2021-2026) (K MT)
Table 104. North America: Unfractionated Heparin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Unfractionated Heparin Sales Forecast by Country (2021-2026) (K MT)
Table 106. Europe: Unfractionated Heparin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Unfractionated Heparin Sales Forecast by Region (2021-2026) (K MT)
Table 108. Asia Pacific: Unfractionated Heparin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Unfractionated Heparin Sales Forecast by Country (2021-2026) (K MT)
Table 110. Latin America: Unfractionated Heparin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Unfractionated Heparin Sales Forecast by Country (2021-2026) (K MT)
Table 112. Middle East and Africa: Unfractionated Heparin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Unfractionated Heparin Players
Table 117. Unfractionated Heparin Customers List
Table 118. Unfractionated Heparin Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Unfractionated Heparin Product Picture
Figure 2. Global Unfractionated Heparin Sales Market Share by Type in 2020 & 2026
Figure 3. Bovine Product Picture
Figure 4. Porcine Product Picture
Figure 5. Global Unfractionated Heparin Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Unfractionated Heparin Report Years Considered
Figure 10. Global Unfractionated Heparin Market Size 2015-2026 (US$ Million)
Figure 11. Global Unfractionated Heparin Sales 2015-2026 (K MT)
Figure 12. Global Unfractionated Heparin Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Unfractionated Heparin Sales Market Share by Region (2015-2020)
Figure 14. Global Unfractionated Heparin Sales Market Share by Region in 2019
Figure 15. Global Unfractionated Heparin Revenue Market Share by Region (2015-2020)
Figure 16. Global Unfractionated Heparin Revenue Market Share by Region in 2019
Figure 17. Global Unfractionated Heparin Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Unfractionated Heparin Revenue in 2019
Figure 19. Unfractionated Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Unfractionated Heparin Sales Market Share by Type (2015-2020)
Figure 21. Global Unfractionated Heparin Sales Market Share by Type in 2019
Figure 22. Global Unfractionated Heparin Revenue Market Share by Type (2015-2020)
Figure 23. Global Unfractionated Heparin Revenue Market Share by Type in 2019
Figure 24. Global Unfractionated Heparin Market Share by Price Range (2015-2020)
Figure 25. Global Unfractionated Heparin Sales Market Share by Application (2015-2020)
Figure 26. Global Unfractionated Heparin Sales Market Share by Application in 2019
Figure 27. Global Unfractionated Heparin Revenue Market Share by Application (2015-2020)
Figure 28. Global Unfractionated Heparin Revenue Market Share by Application in 2019
Figure 29. North America Unfractionated Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Unfractionated Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Unfractionated Heparin Sales Market Share by Country in 2019
Figure 32. North America Unfractionated Heparin Revenue Market Share by Country in 2019
Figure 33. U.S. Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Unfractionated Heparin Market Share by Type in 2019
Figure 38. North America Unfractionated Heparin Market Share by Application in 2019
Figure 39. Europe Unfractionated Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Unfractionated Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Unfractionated Heparin Sales Market Share by Country in 2019
Figure 42. Europe Unfractionated Heparin Revenue Market Share by Country in 2019
Figure 43. Germany Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Unfractionated Heparin Market Share by Type in 2019
Figure 54. Europe Unfractionated Heparin Market Share by Application in 2019
Figure 55. Asia Pacific Unfractionated Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Unfractionated Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Unfractionated Heparin Sales Market Share by Region in 2019
Figure 58. Asia Pacific Unfractionated Heparin Revenue Market Share by Region in 2019
Figure 59. China Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Unfractionated Heparin Market Share by Type in 2019
Figure 82. Asia Pacific Unfractionated Heparin Market Share by Application in 2019
Figure 83. Latin America Unfractionated Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Unfractionated Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Unfractionated Heparin Sales Market Share by Country in 2019
Figure 86. Latin America Unfractionated Heparin Revenue Market Share by Country in 2019
Figure 87. Mexico Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Unfractionated Heparin Market Share by Type in 2019
Figure 94. Latin America Unfractionated Heparin Market Share by Application in 2019
Figure 95. Middle East and Africa Unfractionated Heparin Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Unfractionated Heparin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Unfractionated Heparin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Unfractionated Heparin Revenue Market Share by Country in 2019
Figure 99. Turkey Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Unfractionated Heparin Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Unfractionated Heparin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Unfractionated Heparin Market Share by Type in 2019
Figure 106. Middle East and Africa Unfractionated Heparin Market Share by Application in 2019
Figure 107. North America Unfractionated Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Unfractionated Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Unfractionated Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Unfractionated Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Unfractionated Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Unfractionated Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Unfractionated Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Unfractionated Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Unfractionated Heparin Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Unfractionated Heparin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
ヘパリンカルシウムの世界市場（～2026年） Market Analysis and Insights: Global Calcium Heparin Market The global Calcium Heparin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Calcium Heparin Scope and Market Size Calcium Heparin market is segmented by Type, …- 超低分子量ヘパリン（ULMWH）の世界市場（～2026年） Market Analysis and Insights: Global Ultra-low Molecular Weight Heparin (ULMWH) Market The global Ultra-low Molecular Weight Heparin (ULMWH) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ultra-low Molecular Weight He…
- 牛呼吸器疾患治療の世界市場（～2026年） Bovine respiratory disease (BRD) is a multifactorial and complex disorder caused due to combination of more than one microbial pathogens, impaired host immunity, inadequate housing conditions, and environmental factors. The major factor leading to bovine respiratory diseases are host factors, enviro…
- バイオメディカル用途向け牛由来コラーゲンの世界市場（～2026年） Collagen is a protein exclusively found in animals, specifically in the connective tissues and skin of mammals.Collagen is primarily extracted from bovine, porcine, chicken, and marine. Market Analysis and Insights: Global Bovine-based Collagen for Biomedical Applications Market The global Bovine-ba…
- ブタ血清の世界市場（～2026年） Market Analysis and Insights: Global Porcine Serum Market The global Porcine Serum market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Porcine Serum Scope and Market Size Porcine Serum market is segmented by Type, and by A…